Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 42
1948 44
1949 63
1950 42
1951 49
1952 49
1953 54
1954 82
1955 72
1956 97
1957 77
1958 75
1959 87
1960 86
1961 102
1962 93
1963 96
1964 93
1965 104
1966 101
1967 95
1968 101
1969 107
1970 101
1971 99
1972 68
1973 177
1974 216
1975 317
1976 169
1977 206
1978 233
1979 214
1980 259
1981 233
1982 252
1983 209
1984 219
1985 245
1986 246
1987 291
1988 298
1989 379
1990 412
1991 454
1992 407
1993 468
1994 453
1995 524
1996 640
1997 564
1998 677
1999 850
2000 620
2001 622
2002 572
2003 732
2004 738
2005 580
2006 594
2007 607
2008 693
2009 655
2010 573
2011 634
2012 627
2013 879
2014 756
2015 553
2016 476
2017 502
2018 491
2019 375
2020 582
2021 580
2022 558
2023 528
2024 192

Text availability

Article attribute

Article type

Publication date

Search Results

25,268 results

Results by year

Filters applied: . Clear all
Page 1
RNA modifications in cancer.
Tang Q, Li L, Wang Y, Wu P, Hou X, Ouyang J, Fan C, Li Z, Wang F, Guo C, Zhou M, Liao Q, Wang H, Xiang B, Jiang W, Li G, Zeng Z, Xiong W. Tang Q, et al. Br J Cancer. 2023 Aug;129(2):204-221. doi: 10.1038/s41416-023-02275-1. Epub 2023 Apr 24. Br J Cancer. 2023. PMID: 37095185 Review.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Vermij L, Jobsen JJ, León-Castillo A, Brinkhuis M, Roothaan S, Powell ME, de Boer SM, Khaw P, Mileshkin LR, Fyles A, Leary A, Genestie C, Jürgenliemk-Schulz IM, Crosbie EJ, Mackay HJ, Nijman HW, Nout RA, Smit VTHBM, Creutzberg CL, Horeweg N, Bosse T; TransPORTEC Consortium. Vermij L, et al. Br J Cancer. 2023 Mar;128(7):1360-1368. doi: 10.1038/s41416-023-02141-0. Epub 2023 Jan 23. Br J Cancer. 2023. PMID: 36690721 Free PMC article.
Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk.
Zhou X, Xiao Q, Jiang F, Sun J, Wang L, Yu L, Zhou Y, Zhao J, Zhang H, Yuan S, Timofeeva M, Spiliopoulou A, Mesa-Eguiagaray I, Farrington SM, Law PJ, Houlston RS, Ding K, Dunlop MG, Theodoratou E, Li X. Zhou X, et al. Br J Cancer. 2023 Oct;129(8):1306-1313. doi: 10.1038/s41416-023-02397-6. Epub 2023 Aug 22. Br J Cancer. 2023. PMID: 37608097 Free PMC article.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
O'Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, Hamann U, Imyanitov EN, Andrulis IL, Sharma P, Daly MB, Hake CR, Weitzel JN, Jakubowska A, Godwin AK, Arason A, Bane A, Simard J, Soucy P, Caligo MA, Mai PL, Claes KBM, Teixeira MR, Chung WK, Lazaro C, Hulick PJ, Toland AE, Pedersen IS; HEBON Investigators; Neuhausen SL, Vega A, de la Hoya M, Nevanlinna H, Dhawan M, Zampiga V, Danesi R, Varesco L, Gismondi V, Vellone VG, James PA, Janavicius R, Nikitina-Zake L, Nielsen FC, van Overeem Hansen T, Pejovic T, Borg A, Rantala J, Offit K, Montagna M, Nathanson KL, Domchek SM, Osorio A, García MJ, Karlan BY; GEMO Study Collaborators; De Fazio A, Bowtell D; AOCS Group; McGuffog L, Leslie G, Parsons MT, Dörk T, Speith LM, Dos Santos ES, da Costa AABA, Radice P, Peterlongo P, Papi L, Engel C, Hahnen E, Schmutzler RK, Wappenschmidt B, Easton DF, Tischkowitz M, Singer CF, Tan YY, Whittemore AS, Sieh W, Brenton JD, Yannoukakos D, Fostira F, Konstantopoulou I, Soukupova J, Vocka M; CZECANCA Consortium; Chenevix-Trench G, Pharoah PDP, Antoniou AC, Goldgar DE, Spurdle AB, Michailidou K; Consortium of Investigators of Modifiers of BRCA1/2; Evidence-based Network for the Interpr… See abstract for full author list ➔ O'Mahony DG, et al. Br J Cancer. 2023 Jun;128(12):2283-2294. doi: 10.1038/s41416-023-02263-5. Epub 2023 Apr 19. Br J Cancer. 2023. PMID: 37076566 Free PMC article.
Tamoxifen evolution.
Howell A, Howell SJ. Howell A, et al. Br J Cancer. 2023 Feb;128(3):421-425. doi: 10.1038/s41416-023-02158-5. Epub 2023 Feb 10. Br J Cancer. 2023. PMID: 36765172 Free PMC article. Review. No abstract available.
25,268 results
You have reached the last available page of results. Please see the User Guide for more information.